• Fate Therapeutics, Inc. (NASDAQ:FATE) Given Average Rating of "Hold" by Analysts

    Source: Buzz FX / 03 Dec 2024 03:06:11   America/Chicago


    Fate Therapeutics, Inc. (NASDAQ:FATE) Given Average Rating of "Hold" by Analysts Written by MarketBeat December 3, 2024 Share Link copied to clipboard. Shares of Fate Therapeutics, Inc. ( NASDAQ:FATE - Get Free Report ) have earned an avera
    Read more...
Share on,